Journal Scans
Mortality Results From the Göteborg Randomised Population-Based Prostate-Cancer Screening Trial
First Mortality Results From Göteborg PSA Screening Trial
J Hugosson, S Carlsson, G Aus, S Bergdahl, A Khatami, P Lodding, C-G Pihl, J Stranne, E Holmberg, H Lilja
20100521
2010 Jun 21
Lancet Oncol
Mortality Results From the Göteborg Randomised Population-Based Prostate-Cancer Screening Trial
Lancet Oncol. 2010 Jun 21;[Epub Ahead of Print], J Hugosson, S Carlsson, G Aus, S Bergdahl, A Khatami, P Lodding, C-G Pihl, J Stranne, E Holmberg, H Lilja
TAKE-HOME MESSAGE
Abstract
Abstract
Background: Prostate cancer is one of the leading causes of death from malignant disease among men in the developed world. One strategy to decrease the risk of death from this disease is screening with prostate-specific antigen (PSA); however, the extent of benefit and harm with such screening is under continuous debate. Methods: In December, 1994, 20 000 men born between 1930 and 1944, randomly sampled from the population register, were randomised by computer in a 1:1 ratio to either a screening...
